• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Pfizer

Anonymous board for Pfizer.
Replies
12
Views
2K
Anonymous
Replies
1
Views
841
Anonymous
Replies
32
Views
3K
Anonymous
WTF
Replies
5
Views
1K
Anonymous
Replies
15
Views
2K
Anonymous
Replies
1
Views
4K
Anonymous
Replies
28
Views
2K
Anonymous
Replies
1
Views
819
Anonymous
Replies
6
Views
2K
Anonymous
Replies
3
Views
2K
Anonymous
Replies
7
Views
2K
Anonymous
Replies
17
Views
7K
Anonymous
Replies
2
Views
1K
Anonymous
Replies
33
Views
4K
Anonymous
Replies
0
Views
430
Anonymous